HYALURONIC ACID-CONTAINING ABSORBABLE BIOGRADABLE COVERING

ITEM CODE: TV5795-TV5796

1. The biogradable covering should also have a hybrid knit system.
2. It should secrete hyaluronic acid for over 15 weeks and, after its biogradable feature depletes, it should continue this characteristic with a slow-release feature for an additional 5 weeks.
3. It should be easily usable in cases like bone loss and periosteum, and should exhibit the same properties in other organs besides bone.
4. It must be compatible with hyaluronic organ washing solutions and should also provide the same performance on tissue as it does on bone structures.
5. Thanks to its hybrid structure, it should have hemostatic properties in organs and other bony tissues where bleeding occurs.
6. It should play an effective role in the stabilization of single-piece fractures.
7. It should be resistant to surgical tissue adhesives in the n-butyl group. It should not break down immediately.
8. The product should be sterile and for single use.
9. The product dimensions should be standardized according to the measurements in the health practice directive.
10. There should be clinical support staff within the company or the manufacturing company to support the case.
11. In necessary situations, there should be a biomedical engineer or chemical engineer within the manufacturing company to address possible situations.
12. Companies entering the tender must obtain a suitability declaration from the necessary clinic about the product at least 3 days in advance.